These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9726043)

  • 21. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas.
    Cajaiba MM; Jianhua Luo ; Goodman MA; Fuhrer KA; Rao UN
    Int J Surg Pathol; 2010 Oct; 18(5):319-23. PubMed ID: 20484142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
    Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
    Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment from a human chondrosarcoma of a new immortal cell line with high tumorigenicity in vivo, which is able to form proteoglycan-rich cartilage-like nodules and to respond to insulin in vitro.
    Takigawa M; Pan HO; Kinoshita A; Tajima K; Takano Y
    Int J Cancer; 1991 Jul; 48(5):717-25. PubMed ID: 2071232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of tau proteins and tubulin in extraskeletal myxoid chondrosarcoma, chordoma, and other chondroid tumors.
    Hu B; McPhaul L; Cornford M; Gaal K; Mirra J; French SW
    Am J Clin Pathol; 1999 Aug; 112(2):189-93. PubMed ID: 10439798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chondrosarcoma with dedifferentiated foci. A comparative and ultrastructural study.
    Kahn LB
    Cancer; 1976 Mar; 37(3):1365-75. PubMed ID: 1260656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton.
    Müller S; Söder S; Oliveira AM; Inwards CY; Aigner T
    Mod Pathol; 2005 Aug; 18(8):1088-94. PubMed ID: 15731776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chondrocytic cell differentiation in clear cell chondrosarcoma.
    Aigner T; Dertinger S; Belke J; Kirchner T
    Hum Pathol; 1996 Dec; 27(12):1301-5. PubMed ID: 8958302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor grade-related thallium-201 uptake in chondrosarcomas.
    Kaya GC; Demir Y; Ozkal S; Sengoz T; Manisali M; Baran O; Koc M; Tuna B; Ozaksoy D; Havitcioglu H
    Ann Nucl Med; 2010 May; 24(4):279-86. PubMed ID: 20238186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development.
    Gottschalk D; Fehn M; Patt S; Saeger W; Kirchner T; Aigner T
    Am J Pathol; 2001 May; 158(5):1571-8. PubMed ID: 11337353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias.
    Aigner T; Frischholz S; Dertinger S; Beier F; Girkontaité I; von der Mark K
    Histochem Cell Biol; 1997 Jun; 107(6):435-40. PubMed ID: 9243276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
    Rozeman LB; Hameetman L; van Wezel T; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
    J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abl expression, tumour grade, and apoptosis in chondrosarcoma.
    O'Donovan M; Russell JM; O'Leary JJ; Gillan JA; Lawler MP; Gaffney EF
    Mol Pathol; 1999 Dec; 52(6):341-4. PubMed ID: 10748867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes.
    Waaijer CJ; de Andrea CE; Hamilton A; van Oosterwijk JG; Stringer SE; Bovée JV
    Virchows Arch; 2012 Oct; 461(4):475-81. PubMed ID: 22903264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
    Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dedifferentiated chondrosarcoma of bone. An immunohistochemical and lectin-histochemical study.
    Wick MR; Siegal GP; Mills SE; Thompson RC; Sawhney D; Fechner RE
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(1):23-32. PubMed ID: 2437690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a newly established human chondrosarcoma cell line, CS-OKB.
    Chano T; Okabe H; Saeki Y; Ishizawa M; Matsumoto K; Hukuda S
    Virchows Arch; 1998 Jun; 432(6):529-34. PubMed ID: 9672194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesenchymal chondrosarcoma. An immunohistochemical study.
    Swanson PE; Lillemoe TJ; Manivel JC; Wick MR
    Arch Pathol Lab Med; 1990 Sep; 114(9):943-8. PubMed ID: 2202275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
    Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
    Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). II. An immunohistochemical and electron microscopic study.
    Têtu B; Ordóñez NG; Ayala AG; Mackay B
    Cancer; 1986 Jul; 58(2):287-98. PubMed ID: 3521830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.